Free Trial

Calidi Biotherapeutics (CLDI) Short Interest Ratio & Short Volume

Calidi Biotherapeutics logo
$0.22 -0.01 (-2.31%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$0.23 +0.01 (+3.26%)
As of 06/27/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Calidi Biotherapeutics Short Interest Data

Calidi Biotherapeutics (CLDI) has a short interest of 366,600 shares, representing 1.23% of the float (the number of shares available for trading by the public). This marks a 24.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.01 million shares to cover all short positions.

Current Short Interest
366,600 shares
Previous Short Interest
294,200 shares
Change Vs. Previous Month
+24.61%
Dollar Volume Sold Short
$126.48 thousand
Short Interest Ratio
0.5 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
31,793,000 shares
Float Size
29,700,000 shares
Short Percent of Float
1.23%
Today's Trading Volume
628,399 shares
Average Trading Volume
1,006,971 shares
Today's Volume Vs. Average
62%
Short Selling Calidi Biotherapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Calidi Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLDI Short Interest Over Time

CLDI Days to Cover Over Time

CLDI Percentage of Float Shorted Over Time

Calidi Biotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/2025366,600 shares $126.48 thousand +24.6%1.2%0.5 $0.35
5/31/2025294,200 shares $103.06 thousand +9.2%1.0%0.8 $0.35
5/15/2025269,400 shares $111.80 thousand +18.1%0.9%0.7 $0.42
4/30/2025228,200 shares $110.11 thousand +33.4%0.9%0.4 $0.48
4/15/2025171,100 shares $83.03 thousand -80.4%0.6%0.1 $0.49
3/14/2025639,400 shares $543.49 thousand -17.5%2.6%0.5 $0.85
2/28/2025775,200 shares $681.79 thousand -32.6%3.2%0.5 $0.88
2/14/20251,150,000 shares $1.56 million +66.9%6.6%0.7 $1.36
1/31/2025689,200 shares $522.55 thousand +34.3%4.1%0.3 $0.76
1/15/2025513,300 shares $470.23 thousand +156.5%3.0%0.3 $0.92
6/15/2024857,800 shares $0.00 -16.7%N/A0.4 $0.00
5/31/20241,030,000 shares $0.00 +249.0%N/A0.6 $0.00
5/15/2024295,100 shares $0.00 +547.2%N/A0.3 $0.00
4/30/202445,600 shares $0.00 -96.8%N/A0 $0.00
4/15/20241,430,000 shares $0.00 +859.7%N/A2.3 $0.00
3/31/2024149,000 shares $0.00 +1.2%N/A0.5 $0.00
3/15/2024147,300 shares $0.00 -52.6%N/A0.6 $0.00
2/29/2024310,600 shares $0.00 +0.3%N/A1.3 $0.00
2/15/2024309,700 shares $0.00 +143.1%N/A1.3 $0.00
1/31/2024127,400 shares $0.00 No ChangeN/A1.7 $0.00

CLDI Short Interest - Frequently Asked Questions

What is Calidi Biotherapeutics' current short interest?

Short interest is the volume of Calidi Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 366,600 shares of CLDI short. 1.23% of Calidi Biotherapeutics' shares are currently sold short. Learn More on Calidi Biotherapeutics' current short interest.

Which institutional investors are shorting Calidi Biotherapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Calidi Biotherapeutics: Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Calidi Biotherapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.23% of Calidi Biotherapeutics' floating shares are currently sold short.

Is Calidi Biotherapeutics' short interest increasing or decreasing?

Calidi Biotherapeutics saw a increase in short interest in June. As of June 15th, there was short interest totaling 366,600 shares, an increase of 24.6% from the previous total of 294,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Calidi Biotherapeutics' float size?

Calidi Biotherapeutics currently has issued a total of 31,793,000 shares. Some of Calidi Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Calidi Biotherapeutics currently has a public float of 29,700,000 shares.

How does Calidi Biotherapeutics' short interest compare to its competitors?

1.23% of Calidi Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Calidi Biotherapeutics: Vor Biopharma Inc. (4.19%), Eagle Pharmaceuticals, Inc. (0.46%), Akari Therapeutics PLC (0.11%), Estrella Immunopharma, Inc. (2.51%), Xilio Therapeutics, Inc. (16.07%), LAVA Therapeutics N.V. (0.50%), Lantern Pharma Inc. (3.38%), Scilex Holding Company (8.73%), Barinthus Biotherapeutics PLC Sponsored ADR (0.09%), Kezar Life Sciences, Inc. (0.85%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Calidi Biotherapeutics stock?

Short selling CLDI is an investing strategy that aims to generate trading profit from Calidi Biotherapeutics as its price is falling. CLDI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Calidi Biotherapeutics?

A short squeeze for Calidi Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLDI, which in turn drives the price of the stock up even further.

How often is Calidi Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLDI, twice per month. The most recent reporting period available is June, 15 2025.




This page (NYSE:CLDI) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners